{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:20:03Z","timestamp":1707524403041},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,2]]},"DOI":"10.7759\/cureus.20883","type":"journal-article","created":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T07:03:12Z","timestamp":1641193392000},"source":"Crossref","is-referenced-by-count":1,"title":["Warfarin-Induced Skin Necrosis Despite Enoxaparin Bridging Therapy"],"prefix":"10.7759","author":[{"given":"Mohamed","family":"Wali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad T","family":"Latif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Lockwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman","family":"Saeyeldin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Borz-Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1310\/hjp4911-1044","article-title":"Warfarin-induced skin necrosis","volume":"49","author":"Pourdeyhimi N","year":"2014","unstructured":"Pourdeyhimi N, Bullard Z. Warfarin-induced skin necrosis. Hosp Pharm. 2014, 49:1044-8. 10.1310\/hjp4911-1044","journal-title":"Hosp Pharm"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5811\/cpcem.2017.3.33373","article-title":"An atypical case of warfarin-induced skin necrosis","volume":"1","author":"Sklar LR","year":"2017","unstructured":"Sklar LR, Messman A. An atypical case of warfarin-induced skin necrosis. Clin Pract Cases Emerg Med. 2017, 1:359-61. 10.5811\/cpcem.2017.3.33373","journal-title":"Clin Pract Cases Emerg Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1054\/bjps.2000.3402","article-title":"Warfarin skin necrosis: local and systemic factors","volume":"53","author":"Ad-El DD","year":"2000","unstructured":"Ad-El DD, Meirovitz A, Weinberg A, Kogan L, Arieli D, Neuman A, Linton D. Warfarin skin necrosis: local and systemic factors. Br J Plast Surg. 2000, 53:624-6. 10.1054\/bjps.2000.3402","journal-title":"Br J Plast Surg"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.12.039","article-title":"Warfarin-induced skin necrosis","volume":"61","author":"Nazarian RM","year":"2009","unstructured":"Nazarian RM, Van Cott EM, Zembowicz A, Duncan LM. Warfarin-induced skin necrosis. J Am Acad Dermatol. 2009, 61:325-32. 10.1016\/j.jaad.2008.12.039","journal-title":"J Am Acad Dermatol"},{"key":"ref5","article-title":"Coumarin necrosis--a review of the literature","volume":"103","author":"Cole MS","year":"1988","unstructured":"Cole MS, Minifee PK, Wolma FJ. Coumarin necrosis--a review of the literature. Surgery. 1988, 103:271-7.","journal-title":"Surgery"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2168.2000.01352.x","article-title":"Warfarin induced skin necrosis","volume":"87","author":"Chan YC","year":"2000","unstructured":"Chan YC, Valenti D, Mansfield AO, Stansby G. Warfarin induced skin necrosis. Br J Surg. 2000, 87:266-72. 10.1046\/j.1365-2168.2000.01352.x","journal-title":"Br J Surg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2014.26.1.96","article-title":"Warfarin-induced skin necrosis","volume":"26","author":"Kakagia DD","year":"2014","unstructured":"Kakagia DD, Papanas N, Karadimas E, Polychronidis A. Warfarin-induced skin necrosis. Ann Dermatol. 2014, 26:96-8. 10.5021\/ad.2014.26.1.96","journal-title":"Ann Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.883247","article-title":"Coumadin-induced skin necrosis in a 64 year-old female despite LMWH bridging therapy","volume":"13","author":"Kumar M","year":"2012","unstructured":"Kumar M, Abrina VM, Chittimireddy S. Coumadin-induced skin necrosis in a 64 year-old female despite LMWH bridging therapy. Am J Case Rep. 2012, 13:157-9. 10.12659\/AJCR.883247","journal-title":"Am J Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(59)90403-5","article-title":"Urticaria after administration of warfarin sodium","volume":"3","author":"Sheps SG","year":"1959","unstructured":"Sheps SG, Gifford RW Jr. Urticaria after administration of warfarin sodium. Am J Cardiol. 1959, 3:118-20. 10.1016\/0002-9149(59)90403-5","journal-title":"Am J Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0b013e32835facc8","article-title":"DRESS syndrome induced by acenocoumarol with tolerance to warfarin and dabigatran: a case report","volume":"24","author":"Pi\u00f1ero-Saavedra M","year":"2013","unstructured":"Pi\u00f1ero-Saavedra M, Casta\u00f1o MP, Camarero MO, Milla SL. DRESS syndrome induced by acenocoumarol with tolerance to warfarin and dabigatran: a case report. Blood Coagul Fibrinolysis. 2013, 24:576-8. 10.1097\/MBC.0b013e32835facc8","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.75.882.233","article-title":"Warfarin-induced skin necrosis","volume":"75","author":"Stewart AJ","year":"1999","unstructured":"Stewart AJ, Penman ID, Cook MK, Ludlam CA. Warfarin-induced skin necrosis. Postgrad Med J. 1999, 75:233-5. 10.1136\/pgmj.75.882.233","journal-title":"Postgrad Med J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1965.03080200021006","article-title":"Petechiae, ecchymoses, and necrosis of skin induced by coumarin congeners: rare, occasionally lethal complication of anticoagulant therapy","volume":"192","author":"Nalbandian RM","year":"1965","unstructured":"Nalbandian RM, Mader IJ, Barrett JL, Pearce JF, Rupp EC. Petechiae, ecchymoses, and necrosis of skin induced by coumarin congeners: rare, occasionally lethal complication of anticoagulant therapy. JAMA. 1965, 192:603-8. 10.1001\/jama.1965.03080200021006","journal-title":"JAMA"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1987.tb02513.x","article-title":"Warfarin skin necrosis treated with prostacyclin","volume":"12","author":"Norris PG","year":"1987","unstructured":"Norris PG. Warfarin skin necrosis treated with prostacyclin. Clin Exp Dermatol. 1987, 12:370-2. 10.1111\/j.1365-2230.1987.tb02513.x","journal-title":"Clin Exp Dermatol"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.1993.01680270091012","article-title":"Treatment of coumarin-induced skin necrosis with a monoclonal antibody purified protein C concentrate","volume":"129","author":"Schramm W","year":"1993","unstructured":"Schramm W, Spannagl M, Bauer KA, Rosenberg RD, Birkner B, Linnau Y, Schwarz HP. Treatment of coumarin-induced skin necrosis with a monoclonal antibody purified protein C concentrate. Arch Dermatol. 1993, 129:753-6.","journal-title":"Arch Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v7.i24.4285","article-title":"Successful treatment of warfarin-induced skin necrosis using oral rivaroxaban: a case report","volume":"7","author":"Kamada M","year":"2019","unstructured":"Kamada M, Kenzaka T. Successful treatment of warfarin-induced skin necrosis using oral rivaroxaban: a case report. World J Clin Cases. 2019, 7:4285-91. 10.12998\/wjcc.v7.i24.4285","journal-title":"World J Clin Cases"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-1156","article-title":"Anticoagulant treatment with rivaroxaban in severe protein S deficiency","volume":"132","author":"Martinelli I","year":"2013","unstructured":"Martinelli I, Bucciarelli P, Artoni A, Fossali EF, Passamonti SM, Tripodi A, Peyvandi F. Anticoagulant treatment with rivaroxaban in severe protein S deficiency. Pediatrics. 2013, 132:e1435-9. 10.1542\/peds.2013-1156","journal-title":"Pediatrics"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000572","article-title":"Systematic review and meta-analysis of the efficacy and safety of apixaban compared to rivaroxaban in acute VTE in the real world","volume":"3","author":"Aryal MR","year":"2019","unstructured":"Aryal MR, Gosain R, Donato A, et al.. Systematic review and meta-analysis of the efficacy and safety of apixaban compared to rivaroxaban in acute VTE in the real world. Blood Adv. 2019, 3:2381-7. 10.1182\/bloodadvances.2019000572","journal-title":"Blood Adv"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/78034-warfarin-induced-skin-necrosis-despite-enoxaparin-bridging-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:39Z","timestamp":1707507279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/78034-warfarin-induced-skin-necrosis-despite-enoxaparin-bridging-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,2]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.20883","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,2]]}}}